This compound is a pharmaceutical intermediate used in the synthesis of upadacitinib, a JAK inhibitor. It features a complex polycyclic heteroaromatic system and a benzyl carbamate protecting group.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 2095311-51-4
4-(4-Chlorobutyl)pyridine hydrochloride
pharmaceutical intermediate for API synthesis
TERT-BUTYL TRANS-4-(2-OXOETHYL)CYCLOHEXYLCARBAMATE
pharmaceutical intermediate for API synthesis
Tert-butyl N-(azetidin-3-yl)carbamate hydrochloride
pharmaceutical intermediate for API synthesis
Ethyl 4-amino-2,2-difluorobutanoate hydrochloride
pharmaceutical intermediate for API synthesis
MK-1026 Intermediate-Biayrl Ether
pharmaceutical intermediate
4-[(Acetyloxy)methyl]-5-methyl-1,3-dioxol-2-one
pharmaceutical intermediate
4-(5,5-DIMETHYL-1,3,2-DIOXABORINAN-2-YL)-1H-PYRAZOLE
Pharmaceutical intermediate
3-Methylpyridine-2-carbonitrile
pharmaceutical intermediate
benzyl (3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)pyrrolidine-1-carboxylate
WGODLIHFGCQOPO-SJORKVTESA-N
CC[C@@H]1CN(C[C@@H]1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)OCC5=CC=CC=C5